GlassScriptPhysician profile
Jaesung Lee
NPI 1376550715
$1,506.09
in general payments reported to CMS, 2019-2025
15 companies · $65.17 in 2025
The $65.17 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $154 · 2021: $330 · 2022: $416 · 2023: $162 · 2024: $147 · 2025: $65.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $462.28 | 2019-2024 | |
| Stryker Corporation | $372.69 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $125.00 | 2022 | |
| Intersect Ent, INC. | $106.25 | 2019-2021 | |
| Aerin Medical INC. | $105.58 | 2024 | |
| Genzyme Corporation | $70.88 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $65.17 | 2025 | Dupixent |
| Medtronic, INC. | $43.56 | 2022-2023 | Propel |
| Acclarent, INC | $37.40 | 2019 | |
| Tactile Systems Technology INC | $22.76 | 2019 | |
| Phadia US INC. | $22.42 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $21.60 | 2020 | |
| Glaxosmithkline, LLC. | $18.81 | 2021 | |
| Inspire Medical Systems, INC. | $18.20 | 2024 | Inspire |
| Apria Healthcare LLC | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaesung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.